Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SSKN
2326
DELISTED
Strata Skin Sciences
SSKN
| $1.53M | ﹤0.01% |
133,088
+11,403
| +9% | +$135K |
|
2327
Lisata Therapeutics
LSTA
$10.3M
| $1.53M | ﹤0.01% |
57,266
+28,801
| +101% | +$847K |
|
|
CLSD
2328
DELISTED
Clearside Biomedical
CLSD
| $1.53M | ﹤0.01% |
54,096
+27,903
| +107% | +$822K |
|
2329
Weyco Group
WEYS
$433M
| $1.52M | ﹤0.01% |
70,628
-11,672
| -14% | -$227K |
|
2330
SandRidge Energy
SD
$519M
| $1.52M | ﹤0.01% |
1,180,419
-120,581
| -9% | -$181K |
|
|
QEP
2331
DELISTED
QEP RESOURCES, INC.
QEP
| $1.52M | ﹤0.01% |
1,179,599
-5,342,882
| -82% | -$4.98M |
|
2332
Grupo Cibest SA
CIB
$22.7B
| $1.52M | ﹤0.01% |
57,800
-366,400
| -86% | -$9.6M |
|
|
TVRD
2333
Tvardi Therapeutics
TVRD
$23.5M
| $1.52M | ﹤0.01% |
+2,468
| New | +$1.36M |
|
|
AAIC
2334
DELISTED
Arlington Asset Investment Corp.
AAIC
| $1.52M | ﹤0.01% |
510,481
-242,975
| -32% | -$650K |
|
|
BSQR
2335
DELISTED
BSQUARE Corporation
BSQR
| $1.51M | ﹤0.01% |
951,302
+22,779
| +2% | +$29.2K |
|
2336
Valhi
VHI
$460M
| $1.51M | ﹤0.01% |
143,951
+15,664
| +12% | +$167K |
|
2337
Radcom
RDCM
$176M
| $1.51M | ﹤0.01% |
185,033
+16,100
| +10% | +$116K |
|
|
RNET
2338
DELISTED
RigNet, Inc.
RNET
| $1.5M | ﹤0.01% |
697,400
+166,400
| +31% | +$236K |
|
2339
Cadiz
CDZI
$294M
| $1.5M | ﹤0.01% |
+147,434
| New | +$1.65M |
|
2340
Ponce Financial Group
PDLB
$501M
| $1.5M | ﹤0.01% |
205,221
-6,696
| -3% | -$43.9K |
|
|
PVG
2341
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.5M | ﹤0.01% |
179,100
-875,100
| -83% | -$7.13M |
|
2342
Helios Technologies
HLIO
$2.68B
| $1.5M | ﹤0.01% |
40,175
-12,625
| -24% | -$430K |
|
2343
Carpenter Technology
CRS
$27B
| $1.5M | ﹤0.01% |
61,600
-81,700
| -57% | -$1.81M |
|
|
UBFO
2344
DELISTED
United Security Bancshares
UBFO
| $1.49M | ﹤0.01% |
222,358
-40,200
| -15% | -$252K |
|
2345
Liberty Latin America Class A
LILA
$1.68B
| $1.49M | ﹤0.01% |
238,806
-252,645
| -51% | -$1.66M |
|
2346
StoneX
SNEX
$8.08B
| $1.49M | ﹤0.01% |
136,824
-179,719
| -57% | -$1.56M |
|
2347
RBB Bancorp
RBB
$465M
| $1.48M | ﹤0.01% |
108,700
-36,300
| -25% | -$468K |
|
2348
Hooker Furnishings Corp
HOFT
$158M
| $1.48M | ﹤0.01% |
76,000
-59,965
| -44% | -$959K |
|
|
SEI
2349
Solaris Energy Infrastructure
SEI
$4.17B
| $1.48M | ﹤0.01% |
199,196
-488,679
| -71% | -$3.2M |
|
|
INFI
2350
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.48M | ﹤0.01% |
1,630,638
+245,224
| +18% | +$234K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.